These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34597435)

  • 1. Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancers.
    Ren J; Pang W; Hueniken K; Haddad G; Hope A; Huang SH; Spreafico A; Hansen AR; Perez-Ordonez B; Goldstein DP; Bratman SV; Zhang W; Zhao Y; Xu W; de Almeida JR; Liu G
    Cancer; 2022 Feb; 128(3):497-508. PubMed ID: 34597435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-Reported Symptom Severity, Health-Related Quality of Life, and Emotional Distress Trajectories During and After Radiation Therapy for Human Papillomavirus-Associated Oropharyngeal Cancer: A TROG 12.01 Secondary Analysis.
    McDowell L; Bressel M; King MT; Corry J; Kenny L; Porceddu S; Wratten C; Macann A; Jackson JE; Rischin D
    Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1110-1125. PubMed ID: 36868523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline MD Anderson Symptom Inventory Score is Strongly Associated With Patient-reported Acute and Late Toxicity Following (Chemo) Radiotherapy for Head and Neck Cancers.
    Barker CL; Price GJ; Lee LW; McPartlin A
    Clin Oncol (R Coll Radiol); 2022 Oct; 34(10):683-689. PubMed ID: 35688777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported outcomes of symptom burden in patients receiving surgical or nonsurgical treatment for low-intermediate risk oropharyngeal squamous cell carcinoma: A comparative analysis of a prospective registry.
    Amit M; Hutcheson K; Zaveri J; Lewin J; Kupferman ME; Hessel AC; Goepfert RP; Brandon Gunn G; Garden AS; Ferraratto R; Dave Fuller C; Tam S; Gross ND
    Oral Oncol; 2019 Apr; 91():13-20. PubMed ID: 30926057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the MD Anderson Symptom Inventory-Head-and-Neck-Filipino (MDASI-HN-F): clinical utility of symptom screening among patients with head-and-neck cancer.
    Bacorro WR; Sy Ortin TT; Suarez CG; Mendoza TR; Que JC
    BMJ Support Palliat Care; 2017 Jun; 7(2):140-149. PubMed ID: 25941198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomogram for predicting symptom severity during radiation therapy for head and neck cancer.
    Sheu T; Fuller CD; Mendoza TR; Garden AS; Morrison WH; Beadle BM; Phan J; Frank SJ; Hanna EY; Lu C; Cleeland CS; Rosenthal DI; Gunn GB
    Otolaryngol Head Neck Surg; 2014 Oct; 151(4):619-26. PubMed ID: 25104816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M. D. Anderson symptom inventory head neck (MDASI-HN) questionnaire: Italian language psychometric validation in head and neck cancer patients treated with radiotherapy ± systemic therapy - A study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
    Viganò A; De Felice F; Iacovelli NA; Alterio D; Facchinetti N; Oneta O; Bacigalupo A; Tornari E; Ursino S; Paiar F; Caspiani O; Di Rito A; Musio D; Bossi P; Steca P; Jereczek-Fossa BA; Greco A; Orlandi E
    Oral Oncol; 2021 Apr; 115():105189. PubMed ID: 33549926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Patient-Reported Outcomes in a Population-Based Cohort Following Radiotherapy vs Surgery for Oropharyngeal Cancer.
    Dohopolski MJ; Diao K; Hutcheson KA; Akhave NS; Goepfert RP; He W; Lei XJ; Peterson SK; Shen Y; Sumer BD; Smith BD; Sher DJ
    JAMA Otolaryngol Head Neck Surg; 2023 Aug; 149(8):697-707. PubMed ID: 37382943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.
    Habbous S; Harland LT; La Delfa A; Fadhel E; Xu W; Liu FF; Goldstein D; Waldron J; Huang SH; O'Sullivan B; Liu G
    Head Neck; 2014 Jun; 36(6):802-10. PubMed ID: 23616414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis.
    Rosenthal DI; Mendoza TR; Chambers MS; Burkett VS; Garden AS; Hessell AC; Lewin JS; Ang KK; Kies MS; Gning I; Wang XS; Cleeland CS
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1355-61. PubMed ID: 18501527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric Validation of the M. D. Anderson Symptom Inventory-Head and Neck Module in the Spanish Language.
    Sánchez D; Chala A; Alvarez A; Payan C; Mendoza T; Cleeland C; Sanabria A
    J Pain Symptom Manage; 2016 Jun; 51(6):1055-61. PubMed ID: 26899822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of induction and/or concurrent chemoradiotherapy on acute and late patient-reported symptoms in oropharyngeal cancer: Application of a mixed-model analysis of a prospective observational cohort registry.
    van Dijk LV; Mohamed ASR; Ferrarotto R; McCoy LA; Sharafi CS; Jones E; Steele K; Moreno AC; Lai SY; Garden AS; Myers JN; Rosenthal DI; Fuller CD; Hutcheson KA;
    Cancer; 2021 Jul; 127(14):2453-2464. PubMed ID: 33788956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptom Burden Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Cancer Survivors.
    Aggarwal P; Zaveri JS; Goepfert RP; Shi Q; Du XL; Swartz M; Gunn GB; Lai SY; Fuller CD; Hanna EY; Rosenthal DI; Lewin JS; Piller LB; Hutcheson KA
    JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1066-1076. PubMed ID: 30193299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.
    Falchook AD; Green R; Knowles ME; Amdur RJ; Mendenhall W; Hayes DN; Grilley-Olson JE; Weiss J; Reeve BB; Mitchell SA; Basch EM; Chera BS
    JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):517-23. PubMed ID: 27149571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom burden among head and neck cancer patients in the first year after diagnosis: Association with primary treatment modality.
    Allen-Ayodabo CO; Eskander A; Davis LE; Zhao H; Mahar AL; Karam I; Singh S; Gupta V; Bubis LD; Moody L; Barbera L; Coburn NG
    Oral Oncol; 2019 Dec; 99():104434. PubMed ID: 31630058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing patient-reported symptom burden of long-term head and neck cancer survivors at annual surveillance in survivorship clinic.
    Townes TG; Navuluri S; Pytynia KB; Gunn GB; Kamal MJ; Gilmore KR; Chapman PH; Bell KV; Fournier DM; Janik MA; Joseph LM; Zendehdel S; Hutcheson KA; Goepfert RP
    Head Neck; 2020 Aug; 42(8):1919-1927. PubMed ID: 32112621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group.
    Mendoza TR; Zhao F; Cleeland CS; Wagner LI; Patrick-Miller LJ; Fisch MJ
    Clin Breast Cancer; 2013 Oct; 13(5):325-34. PubMed ID: 23816985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module.
    Rosenthal DI; Mendoza TR; Fuller CD; Hutcheson KA; Wang XS; Hanna EY; Lu C; Garden AS; Morrison WH; Cleeland CS; Gunn GB
    Cancer; 2014 Jul; 120(13):1975-84. PubMed ID: 24711162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life changes over time and predictors in a large head and neck patients' cohort: secondary analysis from an Italian multi-center longitudinal, prospective, observational study-a study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group.
    Viganò A; De Felice F; Iacovelli NA; Alterio D; Ingargiola R; Casbarra A; Facchinetti N; Oneta O; Bacigalupo A; Tornari E; Ursino S; Paiar F; Caspiani O; Di Rito A; Musio D; Bossi P; Steca P; Jereczek-Fossa BA; Caso L; Palena N; Greco A; Orlandi E
    Support Care Cancer; 2023 Mar; 31(4):220. PubMed ID: 36930353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing.
    ; Grant S; Kamal M; Mohamed ASR; Zaveri J; Barrow MP; Gunn GB; Lai SY; Lewin JS; Rosenthal DI; Wang XS; Fuller CD; Hutcheson KA
    Cancer; 2019 May; 125(10):1654-1664. PubMed ID: 30633325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.